A Study of Bevacizumab Plus 5-Flurouracil (5-FU) Based Doublet Chemotherapy as Neoadjuvant Therapy for Participants With Previously Untreated Unresectable Liver-Only Metastases From Colorectal Cancer
Clinical trial NCT01695772 · COMPLETED
Trial details
- NCT number
- NCT01695772
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-16
- Primary completion
- 2015-04-04
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.